Novan Therapeutics raises $50 mln
Novan Therapeutics said Monday it raised $50 million in private financing. Malin Corp. was a new investor. Novan said existing private investors also participated. Durham, N.C.-based Novan is a clinical-stage biotechnology company focused on using nitric oxide therapies in dermatology.
30 March 2015•4 mins read
